The global ultra-long-acting hormonal drug market size was valued at USD 5.40 billion in 2024 and is expected to reach USD 13.96 billion by 2032, at a CAGR of 12.60% during the forecast period
The market growth is largely fueled by the growing demand for long-term contraceptive solutions and hormone-related therapies that require reduced dosing frequency, leading to increased preference for ultra-long-acting hormonal drugs across both developed and emerging regions
4 Views